Effect of Lactobacillus Rhamnosus GG and Bifidobacterium Longum in Children Aged 3 to 5 Years of Villavicencio and Pasto

Sponsor
Cooperative University of Colombia (Other)
Overall Status
Completed
CT.gov ID
NCT03078179
Collaborator
Colgate Palmolive (Industry)
100
3
2
11
33.3
3

Study Details

Study Description

Brief Summary

The objective of this pilot study is to determine if the presence of bacteria with probiotic characteristics (Lactobacillus rhamnosus GG and Bifidobacterium longum) in a commercial milk, control some measures that indicate cariogenic processes.

Condition or Disease Intervention/Treatment Phase
  • Dietary Supplement: Commercial Dairy Cow Milk
  • Dietary Supplement: Commercial Cow Milk with Probiotic
N/A

Detailed Description

Dental caries is a disease caused by a shift in pH balance, resulting in the formation of a biofilm composed mainly of cariogenic microflora. The interaction between this microflora and host factors conditions the deceleration or acceleration of the disease. Some biotechnology tools have been tried based on all this research, including probiotics, intended for a selective control of the etiological agents of caries and the maintenance of oral homeostasis.

Methodology: In this study, preschool children belonging to public preschool in Villavicencio and Pasto, Colombia will be invited to participate. After obtaining parent´s informed consent, the children will start commercial milk (nanPro3 Nestlé) intake without probiotic for 3 months. One week after, they will start commercial milk with probiotic during others 3 months. Clinical and microbiological testing of saliva at baseline, 3 m, and 6m will be performed. Differences in salivary pH (before and after a sugar solution), remineralization and demineralization in early Stage Decay and Established decay tooth (according to ICDAS) and quantification of Streptococci of the mutans group. Expected results: Statistically significant decrease in pH drop, demineralization in decay tooth and quantification of Streptococci of the mutans group.

Study Design

Study Type:
Interventional
Actual Enrollment :
100 participants
Allocation:
Non-Randomized
Intervention Model:
Crossover Assignment
Masking:
Single (Participant)
Primary Purpose:
Other
Official Title:
Effect of Lactobacillus Rhamnosus GG and Bifidobacterium Longum in Children Aged 3 to 5 Years of Villavicencio and Pasto
Actual Study Start Date :
Jun 5, 2017
Actual Primary Completion Date :
Aug 20, 2017
Actual Study Completion Date :
May 5, 2018

Arms and Interventions

Arm Intervention/Treatment
Experimental: Commercial Cow Milk with Probiotic

Probiotic enriched cow milk: 200 ml of commercial nutritive milk fortified with probiotic Lactobacillus rhamnosus and Bifidobacterium longum once a day.

Dietary Supplement: Commercial Cow Milk with Probiotic
The children will initiate the milk intake with probiotic one week after having ingested the milk without probiotics. They will drink the milk with probiotic for 3 months. Clinical and microbiological testing of saliva will be performed. Clinical and microbiological testing of saliva at baseline and at the end will be performed. Differences in salivary pH (before and after a sugar solution), remineralization and demineralization in early Stage Decay and quantification of Streptococci of the mutans group.

Placebo Comparator: Commercial Dairy Cow Milk

200 ml of commercial nutritive milk without probiotic, once a day,

Dietary Supplement: Commercial Dairy Cow Milk
After obtaining parent´s informed consent and the baseline examination, from 3 to 5 years old, will start commercial dairy cow milk intake without probiotic (placebo) for 3 months. Clinical and microbiological testing of saliva at baseline and at the end will be performed. Differences in salivary pH (before and after a sugar solution), remineralization and demineralization in early Stage Decay and quantification of Streptococci of the mutans group.

Outcome Measures

Primary Outcome Measures

  1. Change in remineralization of tooth decay [3 months]

    DIAGNOdent peak reading in three moments,at the beginning and at the end of the milk without probiotic (after 3 months), and at the end of the milk with probiotic (after 3 months)

Secondary Outcome Measures

  1. Change of pH of saliva before and after a rinse with sugar. [3 months]

    Saliva pH test in three moments,at the beginning and at the end of the milk without probiotic (after 3 months), and at the end of the milk with probiotic (after 3 months).

  2. Change of Dental Plaque Index [3 months]

    Silness-Löe plaque index n three moments,at the beginning and at the end of the milk without probiotic (after 3 months), and at the end of the milk with probiotic (after 3 months).

  3. Change of concentration of group mutans streptococci in saliva [3 months]

    Co(after 3 months).lony Forming Units (CFUs) determination in three moments,at the beginning and at the end of the milk without probiotic (after 3 months), and at the end of the milk with probiotic

Eligibility Criteria

Criteria

Ages Eligible for Study:
3 Years to 5 Years
Sexes Eligible for Study:
All
Accepts Healthy Volunteers:
Yes
Inclusion Criteria:
  • Pre-school children from age 3 to 5.

  • Healthy children from a general health perspective, with early stage decay and established decay

Exclusion Criteria:
  • Children with systemic disorders who need special care and / or who have intolerance to milk drinks or allergy to any of the components of the experimental and / or placebo beverage.

  • Children who don't like milk.

  • Children whit severe decay

Contacts and Locations

Locations

Site City State Country Postal Code
1 Hogar Infantil 20 de Julio Villavicencio Meta Colombia 500001
2 Hogar Infantil La Esperanza Villavicencio Meta Colombia 500001
3 Cdi Nidos Nutrir Pasto Colombia

Sponsors and Collaborators

  • Cooperative University of Colombia
  • Colgate Palmolive

Investigators

  • Principal Investigator: María del Pilar Angarita, PhD, Cooperative University of Colombia

Study Documents (Full-Text)

More Information

Publications

Responsible Party:
Cooperative University of Colombia
ClinicalTrials.gov Identifier:
NCT03078179
Other Study ID Numbers:
  • ID 1532
First Posted:
Mar 13, 2017
Last Update Posted:
Jul 23, 2018
Last Verified:
Jun 1, 2018
Individual Participant Data (IPD) Sharing Statement:
Undecided
Plan to Share IPD:
Undecided
Studies a U.S. FDA-regulated Drug Product:
No
Studies a U.S. FDA-regulated Device Product:
No
Product Manufactured in and Exported from the U.S.:
No
Keywords provided by Cooperative University of Colombia
Additional relevant MeSH terms:

Study Results

No Results Posted as of Jul 23, 2018